Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
We have interviewed Dr. Raúl Córdoba, MD, PhD. Head of the Lymphoma Unit at the Fundacion Jimenez Diaz University Hospital, Madrid, Spain. Chair of the EHA Scientific Working Group. Thanks to the advances we have made, especially in the last decade, in new treatment options for cancer patients, we have
A new center joins the RESILIENCE project. It is the hospital La Paz in Madrid, awarded several times as the best public hospital in Spain, which welcomed us with open arms and with which we are looking forward to collaborate. We started the year 2023 more committed than ever to
The new Clinical Practice Guidelines of Cardio-Oncology were released in August 2022. RESILIENCE is proud to count with two relevant members of the Task Force as project investigators. Teresa López-Fernández is the Chairperson of this Clinical Practice Guideline and co-Principal investigator of European Society of Cardiology (ESC) in RESILIENCE project.
We have had the opportunity to talk about resilience with two great figures of Spanish sports, Almudena Cid and Julio García Mera. They have shared with us how resilience has allowed them to face the most difficult moments of their sports careers and how they have transferred that resilience to
On Thursday, November 17th we participated in the XXII Week of Science and Innovation in Madrid with our activity “Visit to a CNIC laboratory to learn about the use of technology and its innovative aspects in the RESILIENCE project”. More than 60 people of different ages, students and professionals from
On November 2nd, RESILIENCE team traveled to Portugal to visit the two medical centers that have just joined our RESILIENCE project, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO) and Hospital Da Luz. Both hospitals will collaborate in the growth of our project in the Portuguese country; IPO
